# Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

> **NCT05551299** · PHASE4 · RECRUITING · sponsor: **University of Leipzig** · enrollment: 258 (estimated)

## Conditions studied

- Hilar Cholangiocarcinoma

## Interventions

- **DRUG:** Photosensitizer
- **PROCEDURE:** Radiofrequency ablation (RFA)

## Key facts

- **NCT ID:** NCT05551299
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-10
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2025-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551299, "Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT05551299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*